MDX2001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MDX2001, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]